Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ogden syndrome is a rare, genetic progeroid syndrome characterized by a variable phenotype including postnatal growth delay, severe global developmental delay, hypotonia, non-specific dysmorphic facies with aged appearance and cryptorchidism, as well as cardiac arrthymias and skeletal anomalies. Patients typically present with widely opened fontanels, mainly truncal hypotonia, a waddling gait with hypertonia of the extremities, small hands and feet, broad great toes, scoliosis and redundant skin with lack of subcutaneous fat.
Features include always present findings: Pulmonary artery stenosis, Global developmental delay, and Microvesicular hepatic steatosis; and common findings: Downslanted palpebral fissures, Macrotia, Proptosis, and Narrow palate and others. 100 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Irritability, Enlarged brain ventricles (ventriculomegaly), Difficulty swallowing (dysphagia) |
Heart and blood vessels | 8 | Left atrial enlargement, Premature atrial contractions, Secundum atrial septal defect |
Head and neck | 7 | Microcephaly, Narrow palate, Thin upper lip vermilion |
Digestive system | 7 | Diarrhea, Difficulty swallowing (dysphagia), Vomiting |
Lungs and breathing | 6 | Peripheral pulmonary artery stenosis, Pulmonary hypoplasia, Pulmonary artery stenosis |
Skin | 5 | Redundant skin, Redundant neck skin, Lymphedema |
Growth and development | 2 | Short stature, Postnatal growth retardation |
Arms and legs | 2 | Long fingers, Clinodactyly of the 5th finger |
Kidneys and urinary system | 2 | Polycystic kidney dysplasia, Enlarged kidney |
Bones and joints | 2 | Sideways curvature of the spine (scoliosis), Delayed skeletal maturation |
Pregnancy and birth | 2 | Decreased fetal movement, Congenital hip dislocation |
Ears | 1 | Recurrent otitis media |
Blood and immune system | 1 | Low iron red blood cell count (iron deficiency anemia) |
Muscles | 1 | Low muscle tone (hypotonia) |
Eyes | 1 | Bilateral ptosis |
Lab test results | 1 | Hyperbilirubinemia |
NAA10 encodes N-alpha-acetyltransferase 10, NatA catalytic subunit (235 aa). Catalytic subunit of N-terminal acetyltransferase complexes which display alpha (N-terminal) acetyltransferase activity. Acetylates amino termini that are devoid of initiator methionine. Highest expression in Uterus (78.8 TPM) and Cells Cultured fibroblasts (78.7 TPM).
Ogden syndrome is associated with mutations in the NAA10 gene on chromosome X.
NAA10 is classified as a druggable target (Enzyme and Kinase categories) with score 0.0.
Genetic testing for NAA10 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Ogden syndrome has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 14 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Ogden syndrome.
45 publications have been identified in PubMed for Ogden syndrome. Research spans Basic Science / Preclinical (63%), Review / Meta-Analysis (16%), and Case Report / Case Series (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 27 | 63% |
Research summaries | 7 | 16% |
Patient case studies | 3 | 7% |
Clinical study results | 2 | 5% |
Disease patterns and progression | 2 | 5% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
Bühler A (2026). [PMID: 41973310](https://pubmed.ncbi.nlm.nih.gov/41973310/). *Mol Cell Pediatr*. [Review / Meta-Analysis]
Jiao K (2026). [PMID: 41423010](https://pubmed.ncbi.nlm.nih.gov/41423010/). *Cell Signal*. [Basic Science / Preclinical]
Aydin Gumus A (2026). [PMID: 41384780](https://pubmed.ncbi.nlm.nih.gov/41384780/). *Psychiatr Genet*. [Case Report / Case Series]
Wei W (2026). [PMID: 41735227](https://pubmed.ncbi.nlm.nih.gov/41735227/). *J Gastroenterol Hepatol*. [Basic Science / Preclinical]
Sun J (2026). [PMID: 42139339](https://pubmed.ncbi.nlm.nih.gov/42139339/). *Sci Adv*. [Basic Science / Preclinical]
Piedade WP (2026). [PMID: 42146379](https://pubmed.ncbi.nlm.nih.gov/42146379/). *bioRxiv*. [Basic Science / Preclinical]
Xu L (2026). [PMID: 41615304](https://pubmed.ncbi.nlm.nih.gov/41615304/). *FASEB J*. [Basic Science / Preclinical]
Makwana R (2026). [PMID: 40293509](https://pubmed.ncbi.nlm.nih.gov/40293509/). *Pediatr Cardiol*. [Clinical Trial Publication]
Brown WD (2026). [PMID: 42135266](https://pubmed.ncbi.nlm.nih.gov/42135266/). *Am J Med Genet A*. [Case Report / Case Series]
Fan C (2026). [PMID: 42165278](https://pubmed.ncbi.nlm.nih.gov/42165278/). *FASEB J*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 5:35 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Ogden syndrome